Modifiable factors associated with postoperative atrial fibrillation in older patients with hip fracture in an orthogeriatric care pathway: a nested case-control study.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
09 11 2022
Historique:
received: 13 05 2022
accepted: 26 09 2022
entrez: 10 11 2022
pubmed: 11 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Few data are available regarding post-operative atrial fibrillation (POAF) in non-cardiothoracic surgery, particularly orthopedic surgery. Hence, given the frequent incidence of POAF after surgery and its marked impact, we need to identify modifiable factors associated with POAF after hip fracture surgery in older patients. We conducted a nested case-control study in the unit for perioperative geriatric care of an academic hospital in Paris from July 1, 2009 to December 31, 2019, enrolling all consecutive patients aged ≥ 70 years with hip fracture surgery and no history of permanent AF before admission (retrospective analysis of prospectively collected data). Patients with and without POAF were matched 1:5 on 5 baseline characteristics (age, hypertension, diabetes, coronary artery disease, cardiac failure). Of the 757 patients included, 384 were matched, and 64 had POAF. The incidence of POAF was 8.5%. The mean age was 86 ± 6 years, 298 (78%) patients were female, and the median Charlson Comorbidity Index was 6 (interquartile range 4-8). The median time from surgery to the occurrence of POAF was 2 days (1-4). On multivariable conditional logistic regression analysis (matched cohort), the modifiable factors present at admission associated with POAF were time to surgery > 48 h (odds ratio [OR] = 1.66, 95% confidence interval [1.01-2.81]) and > 2 units of packed red blood cells (OR = 3.94, [1.50-10.03]). This study provides new information about POAF in older patients with hip fracture surgery, a surgical emergency whose complexity requires multidisciplinary care.

Sections du résumé

BACKGROUND
Few data are available regarding post-operative atrial fibrillation (POAF) in non-cardiothoracic surgery, particularly orthopedic surgery. Hence, given the frequent incidence of POAF after surgery and its marked impact, we need to identify modifiable factors associated with POAF after hip fracture surgery in older patients.
METHODS
We conducted a nested case-control study in the unit for perioperative geriatric care of an academic hospital in Paris from July 1, 2009 to December 31, 2019, enrolling all consecutive patients aged ≥ 70 years with hip fracture surgery and no history of permanent AF before admission (retrospective analysis of prospectively collected data). Patients with and without POAF were matched 1:5 on 5 baseline characteristics (age, hypertension, diabetes, coronary artery disease, cardiac failure).
RESULTS
Of the 757 patients included, 384 were matched, and 64 had POAF. The incidence of POAF was 8.5%. The mean age was 86 ± 6 years, 298 (78%) patients were female, and the median Charlson Comorbidity Index was 6 (interquartile range 4-8). The median time from surgery to the occurrence of POAF was 2 days (1-4). On multivariable conditional logistic regression analysis (matched cohort), the modifiable factors present at admission associated with POAF were time to surgery > 48 h (odds ratio [OR] = 1.66, 95% confidence interval [1.01-2.81]) and > 2 units of packed red blood cells (OR = 3.94, [1.50-10.03]).
CONCLUSIONS
This study provides new information about POAF in older patients with hip fracture surgery, a surgical emergency whose complexity requires multidisciplinary care.

Identifiants

pubmed: 36352354
doi: 10.1186/s12877-022-03556-9
pii: 10.1186/s12877-022-03556-9
pmc: PMC9644640
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

845

Informations de copyright

© 2022. The Author(s).

Références

J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):438-443
pubmed: 27231388
Medicine (Baltimore). 2017 Feb;96(7):e6169
pubmed: 28207554
J Am Geriatr Soc. 2018 Jul;66(6):1151-1157
pubmed: 29676780
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Stroke. 2019 Jun;50(6):1364-1371
pubmed: 31043148
N Engl J Med. 2011 Dec 29;365(26):2453-62
pubmed: 22168590
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Anesthesiol Res Pract. 2021 Apr 28;2021:5527199
pubmed: 34007270
J Hosp Med. 2012 Nov-Dec;7(9):713-6
pubmed: 22956471
Anesthesiology. 2014 Dec;121(6):1336-41
pubmed: 25299743
JAMA. 2019 Jun 11;321(22):2231-2232
pubmed: 31074763
PLoS One. 2014 Jan 15;9(1):e83795
pubmed: 24454708
Br J Anaesth. 2017 Jun 1;118(6):952-954
pubmed: 28575342
J Clin Med. 2020 Jul 24;9(8):
pubmed: 32722204
Clin Geriatr Med. 2014 May;30(2):279-84
pubmed: 24721367
Int J Cardiol. 2017 Jan 15;227:58-60
pubmed: 27846465
Intern Emerg Med. 2021 Mar;16(2):333-338
pubmed: 32440983
J Alzheimers Dis. 2017;56(1):145-156
pubmed: 27911302
Nat Rev Cardiol. 2019 Jul;16(7):417-436
pubmed: 30792496
ISRN Cardiol. 2011;2011:203179
pubmed: 22347631
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
J Clin Epidemiol. 1996 Aug;49(8):907-16
pubmed: 8699212
JAMA. 2009 Oct 14;302(14):1573-9
pubmed: 19826027
Arch Osteoporos. 2017 Aug 29;12(1):77
pubmed: 28852954
PLoS One. 2012;7(10):e46175
pubmed: 23056256
Int J Biostat. 2009 Jan 06;5(1):Article 1
pubmed: 20231866
J Cardiothorac Vasc Anesth. 2009 Feb;23(1):22-7
pubmed: 18834823
Am Heart J. 2012 Dec;164(6):918-24
pubmed: 23194493
JAMA. 2001 May 9;285(18):2370-5
pubmed: 11343485
Eur J Anaesthesiol. 2021 Sep 1;38(9):1003-1005
pubmed: 34397528
J Arthroplasty. 2018 Sep;33(9):3016-3019
pubmed: 29793849
J Am Med Dir Assoc. 2022 Apr;23(4):623-630.e2
pubmed: 34653382
Cancer Treat Rep. 1985 Oct;69(10):1071-77
pubmed: 4042087
Med Care. 1976 May;14(5 Suppl):116-8
pubmed: 132585
JAMA. 2019 Feb 19;321(7):686-696
pubmed: 30778597
JAMA. 2001 Jun 6;285(21):2736-42
pubmed: 11386929
J Thromb Haemost. 2015 Jun;13 Suppl 1:S304-12
pubmed: 26149040
Cochrane Database Syst Rev. 2021 Dec 21;12:CD002042
pubmed: 34932836

Auteurs

Pierre Gay (P)

Assistance Publique - Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Département de gériatrie, Paris, France.

Bastien Genet (B)

Assistance Publique - Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Département de gériatrie, Paris, France.

Audrey Rouet (A)

Assistance Publique - Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Département de gériatrie, Paris, France.

Rana Alkouri (R)

Assistance Publique - Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Département de biochimie, Paris, France.

Judith Cohen-Bittan (J)

Assistance Publique - Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Département de gériatrie, Paris, France.

Jacques Boddaert (J)

Assistance Publique - Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Département de gériatrie, Paris, France.
Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses (Cimi), Paris, France.

Lorène Zerah (L)

Assistance Publique - Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Département de gériatrie, Paris, France. lorene.zerah@aphp.fr.
Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France. lorene.zerah@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH